- Home
- SRFM vs TENX Comparison
SRFM vs TENX Comparison
Compare SRFM & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- TENX
- Stock Information
- Founded
- SRFM 2011
- TENX 1967
- Country
- SRFM United States
- TENX United States
- Employees
- SRFM N/A
- TENX N/A
- Industry
- SRFM Transportation Services
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- SRFM Consumer Discretionary
- TENX Health Care
- Exchange
- SRFM Nasdaq
- TENX Nasdaq
- Market Cap
- SRFM 62.8M
- TENX 19.5M
- IPO Year
- SRFM 2023
- TENX N/A
- Fundamental
- Price
- SRFM $3.33
- TENX $5.61
- Analyst Decision
- SRFM Hold
- TENX Strong Buy
- Analyst Count
- SRFM 2
- TENX 4
- Target Price
- SRFM $3.40
- TENX $20.67
- AVG Volume (30 Days)
- SRFM 604.8K
- TENX 67.4K
- Earning Date
- SRFM 11-14-2024
- TENX 11-13-2024
- Dividend Yield
- SRFM N/A
- TENX N/A
- EPS Growth
- SRFM N/A
- TENX N/A
- EPS
- SRFM N/A
- TENX N/A
- Revenue
- SRFM $118,212,000.00
- TENX N/A
- Revenue This Year
- SRFM $102.41
- TENX N/A
- Revenue Next Year
- SRFM $47.46
- TENX N/A
- P/E Ratio
- SRFM N/A
- TENX N/A
- Revenue Growth
- SRFM 198.78
- TENX N/A
- 52 Week Low
- SRFM $0.90
- TENX $2.77
- 52 Week High
- SRFM $11.83
- TENX $27.36
- Technical
- Relative Strength Index (RSI)
- SRFM 50.96
- TENX 54.30
- Support Level
- SRFM $2.76
- TENX $5.70
- Resistance Level
- SRFM $4.50
- TENX $6.01
- Average True Range (ATR)
- SRFM 0.81
- TENX 0.47
- MACD
- SRFM -0.18
- TENX -0.08
- Stochastic Oscillator
- SRFM 20.92
- TENX 12.15
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.